Cours Beleave Inc. Canadian Securities Exchange
Actions
BE
CA0775611084
Produits pharmaceutiques
CA 2018 | - | CA 2019 | 2,37 3,24 2,15 | Capitalisation | 30,37 M 41,39 M 27,45 M |
---|---|---|---|---|---|
Résultat net 2018 | -12 M -16,36 M -10,85 M | Résultat net 2019 | -33 M -44,98 M -29,82 M | VE / CA 2018 | - |
Trésorerie nette 2018 | 5,2 M 7,09 M 4,7 M | Dette nette 2019 | 10,32 M 14,06 M 9,32 M | VE / CA 2019 | 17 137 012 x |
PER 2018 |
-4,72
x | PER 2019 |
-0,76
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 98,39% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+45,15% | 6,38 Md | |
-14,00% | 4,59 Md | |
+9,54% | 3,39 Md | |
-8,99% | 3,2 Md | |
-2,41% | 2,52 Md | |
+50,03% | 2 Md | |
-6,97% | 1,7 Md | |
-0,31% | 1,65 Md | |
-10,61% | 1,58 Md |